The Infant Phototherapy Market is expected to reach US$ 140.92 million in 2033 from US$ 99.95 million in 2024, with a CAGR of 3.89% from 2025 to 2033. The market for infant phototherapy devices is expected to grow due to factors such as an increase in preterm deliveries, a rise in incidences of neonatal jaundice, device technology advancements, better healthcare infrastructure, and more knowledge of successful newborn therapies.
Jaundice is becoming more common, particularly in premature infants, due to liver issues, infections, enzyme deficiencies, and abnormalities in red blood cells. This, when combined with notable advancements in the global healthcare system, is one of the main drivers supporting the market's expansion. Devices for infant phototherapy use light that is absorbed by the skin of the baby to convert bilirubin into other chemicals. Additionally, these devices lead to electrolyte imbalance, water loss, bronze baby syndrome, circadian rhythm disruption, and thermal environment imbalance. In order to reduce the negative effects of phototherapy, major manufacturers are creating new light devices and substitute agents, which is driving the market's expansion. Additionally, they are launching adequate eye protection that is affordable, simple to use, detachable, and suitable for newborns. This is having a good impact on the use of infant phototherapy equipment in rural hospitals with limited resources and inexperienced staff, as is the development of efficient, energy-efficient, portable, and cleanable devices.
The global infant phototherapy market size was valued at US$ 99.95 million in 2024 and is expected to reach US$ 140.92 million in 2033.
2. What is the Infant Phototherapy industry growth rate?
The global infant Phototherapy market is expected to expand at a compound annual growth rate (CAGR) of 3.89% from 2025 to 2033.
3. Who are the key players in Infant Phototherapy industry?
Ningbo David Medical Device Co., Ltd, Koninklijke Philips N.V., General Electric Company, Inspiration Healthcare Group Plc, Drägerwerk AG & Co. KGaA, Ibis Medical Equipment and Systems Pvt Ltd., Weyer GmbH and Natus Medical Incorporated are prominent in the global infant phototherapy market.
4. What are the factors driving the Infant Phototherapy industry?
Growth drivers of the infant phototherapy devices market include rising preterm births, increasing neonatal jaundice cases, technological advancements in devices, improved healthcare infrastructure, and growing awareness about effective treatments for newborns.
5. Which Region held the largest market share in the Infant Phototherapy industry?
North America is expected to hold the largest market share in the industry.
6. What segments are covered in the Infant Phototherapy market report?
Light Source, Configuration, End User and Countries segment are covered in this report.
Infant Phototherapy Industry Overview
Neonatal jaundice can be treated with the help of clinically validated and cutting-edge infant phototherapy devices. By exposing the baby to light that oxidizes the bilirubin in the blood, they also aid in the treatment of hyperbilirubinemia. They lessen the requirement for exchange transfusions in newborns and stop the neurotoxic consequences of elevated serum unconjugated bilirubin. They have an hour meter to monitor bulb life and infant treatment time, and they are either wrapped around and placed under or near the baby. Their use in hospitals and assisted living facilities worldwide is growing due to their affordability and convenience.Jaundice is becoming more common, particularly in premature infants, due to liver issues, infections, enzyme deficiencies, and abnormalities in red blood cells. This, when combined with notable advancements in the global healthcare system, is one of the main drivers supporting the market's expansion. Devices for infant phototherapy use light that is absorbed by the skin of the baby to convert bilirubin into other chemicals. Additionally, these devices lead to electrolyte imbalance, water loss, bronze baby syndrome, circadian rhythm disruption, and thermal environment imbalance. In order to reduce the negative effects of phototherapy, major manufacturers are creating new light devices and substitute agents, which is driving the market's expansion. Additionally, they are launching adequate eye protection that is affordable, simple to use, detachable, and suitable for newborns. This is having a good impact on the use of infant phototherapy equipment in rural hospitals with limited resources and inexperienced staff, as is the development of efficient, energy-efficient, portable, and cleanable devices.
Growth Drivers for the Infant Phototherapy Market
Rising neonatal jaundice cases
Rising neonatal jaundice cases are a significant growth driver for the infant phototherapy devices market. According to a BMJ Journals article, during the first week of life, 60% of term and 80% of preterm infants experience neonatal jaundice. This high incidence fuels the demand for effective treatment options like phototherapy devices. As early diagnosis and intervention are crucial, the growing awareness of jaundice management and advancements in phototherapy technology contribute to increasing market growth, improving outcomes for newborns worldwide.Improved healthcare infrastructure
One of the main factors propelling the market for newborn phototherapy devices is improved healthcare infrastructure. The need for cutting-edge medical equipment, like as phototherapy equipment, is growing as healthcare systems in both established and emerging nations seek to improve newborn care facilities. Better-equipped clinics and hospitals are increasing their capacity to adequately treat newborn jaundice, particularly in poorer nations. Additional evidence for the requirement for effective phototherapy equipment comes from the availability of specialized care units and qualified medical personnel. The increased use of phototherapy solutions for babies around the world is a result of this expanding infrastructure, which makes it possible to detect and treat neonatal jaundice earlier.Technological Advancements
The market for newborn phototherapy equipment is growing significantly due to technological improvements. Improvements in infant jaundice treatment outcomes have been made possible by innovations including more energy-efficient LED light sources, portable and user-friendly equipment, and adjustable settings. In addition to being more effective, modern phototherapy equipment has improved safety features that guard against burns and dehydration. Additionally, jaundice levels can be tracked in real time by interaction with monitoring equipment. The effectiveness and comfort of treatment are improved by these developments, which encourage more hospitals and clinics around the world to use phototherapy equipment.Challenges in the Infant Phototherapy Market
High Costs
The market for infant phototherapy equipment is severely hampered by high prices, especially in low- and middle-income nations. Many healthcare facilities cannot afford advanced devices, such as those with integrated monitoring systems and contemporary LED technology. This may restrict access to efficient neonatal jaundice therapy, particularly in impoverished or rural locations. Furthermore, hospitals and clinics may be discouraged from using new technologies due to the large initial expenditure. Even though phototherapy has many advantages, universal access to and use of these necessary tools is hampered by the cost to healthcare institutions.Regulatory Barriers
The market for infant phototherapy equipment is severely hampered by regulatory barriers because every nation has different requirements and approval procedures. Adherence to various rules, including those pertaining to safety, quality assurance, and certification, may cause delays in product releases and raise expenses for producers. Extensive clinical trials and paperwork are required in many locations in order to gain the required approvals from regulatory organizations such as the FDA or EMA. Furthermore, strict regulations in some nations regarding neonatal care equipment may make it difficult for smaller producers to enter the market. The adoption of novel phototherapy technologies may be slowed down and market access restricted by these regulatory hurdles.Infant Phototherapy Market Overview by Regions
With North America and Europe leading the way in sophisticated healthcare infrastructure and technological adoption, the newborn phototherapy industry is expanding globally. Growing healthcare access and understanding of newborn care are driving the rapid expansion of Asia-Pacific and Latin America. Africa confronts obstacles, but with rising healthcare spending and awareness, growth is anticipated.United States Infant Phototherapy Market
High neonatal care standards, sophisticated healthcare infrastructure, and growing awareness of neonatal jaundice are the main factors propelling the infant phototherapy market in the United States. The need for efficient phototherapy equipment is increasing as the frequency of preterm deliveries and occurrences of newborn jaundice rises. Technological developments in portable electronics and LED-based phototherapy systems also contribute to market expansion. Infant phototherapy equipment use and development in the U.S. market is further supported by robust healthcare legislation, better reimbursement alternatives, and a growing number of specialist neonatal units.Germany Infant Phototherapy Market
Germany's robust healthcare system and excellent neonatal care standards are fueling the country's growing infant phototherapy sector. With around 220,000 babies born each year with neonatal jaundice affecting 60% of term and 80% of preterm babies, there is a high need for phototherapy equipment. The industry is expanding thanks to technological developments such portable LED devices and enhanced safety features. Furthermore, the adoption of these devices is encouraged by German healthcare legislation and payment schemes, which promote the market's ongoing growth and accessibility.India Infant Phototherapy Market
The rising prevalence of neonatal jaundice, particularly in preterm infants, is driving the rapid growth of the infant phototherapy market in India. The need for phototherapy technologies is being driven by the need for efficient neonatal care. The industry gains from government programs to improve mother and child health, increased knowledge among medical professionals, and advancements in healthcare infrastructure. Energy-efficient, reasonably priced gadgets such as LED-based phototherapy systems are becoming more popular. But issues like cost and availability to medical care in rural areas still exist, which prevents some communities from widely implementing cutting-edge phototherapy equipment.UAE Infant Phototherapy Market
Improvements in healthcare infrastructure and increased awareness of neonatal jaundice are driving growth in the UAE infant phototherapy market. The need for efficient phototherapy equipment is fueled by the nation's high standards for neonatal care as well as an increase in preterm births. Technological advancements like portable LED phototherapy systems are becoming more and more well-liked. Government programs to enhance the health of mothers and children also contribute to market expansion. However, in certain areas, access may be restricted due to high device costs, which would make broader adoption difficult.Infant Phototherapy Device Market Segments
Light Source - Market breakup by 3 viewpoints:
- Fluorescent Lamps
- Light Emitting Diodes
- Quartz Halogen Lamps
- Gas Discharge Tubes
Configuration - Market breakup by 2 viewpoints:
- Mobile Device
- Fixed Device
End User - Market breakup by 2 viewpoints:
- Hospitals
- Neonatal Clinics
Country - Market breakup of 25 Countries:
North America- United States
- Canada
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherland
- Turkey
- China
- Japan
- India
- South Korea
- Thailand
- Malaysia
- Indonesia
- Australia
- New Zealand
- Brazil
- Mexico
- Argentina
- Saudi Arabia
- UAE
- South Africa
Company Analysis: Overview, Product Portfolio, Recent Development, Revenue Analysis:
- Ningbo David Medical Device Co.
- Ltd, Koninklijke Philips N.V.
- General Electric Company
- Inapiration Healthcare Group Plc
- Drägerwerk AG & Co. KGaA
- Ibis Medical Equipment and Systems Pvt Ltd.
- Weyer GmbH
- Natus Medical Incorporated.
Key Questions Answered in Report
1. How big is the Infant Phototherapy industry?The global infant phototherapy market size was valued at US$ 99.95 million in 2024 and is expected to reach US$ 140.92 million in 2033.
2. What is the Infant Phototherapy industry growth rate?
The global infant Phototherapy market is expected to expand at a compound annual growth rate (CAGR) of 3.89% from 2025 to 2033.
3. Who are the key players in Infant Phototherapy industry?
Ningbo David Medical Device Co., Ltd, Koninklijke Philips N.V., General Electric Company, Inspiration Healthcare Group Plc, Drägerwerk AG & Co. KGaA, Ibis Medical Equipment and Systems Pvt Ltd., Weyer GmbH and Natus Medical Incorporated are prominent in the global infant phototherapy market.
4. What are the factors driving the Infant Phototherapy industry?
Growth drivers of the infant phototherapy devices market include rising preterm births, increasing neonatal jaundice cases, technological advancements in devices, improved healthcare infrastructure, and growing awareness about effective treatments for newborns.
5. Which Region held the largest market share in the Infant Phototherapy industry?
North America is expected to hold the largest market share in the industry.
6. What segments are covered in the Infant Phototherapy market report?
Light Source, Configuration, End User and Countries segment are covered in this report.
Table of Contents
1. Introduction2. Research & Methodology3. Executive Summary5. Global Infant Phototherapy Device Market
4. Market Dynamics
6. Market Share Analysis
7. Light Source
8. Configuration
9. End User
10. Countries
11. Porter’s Five Forces Analysis
12. SWOT Analysis
13. Key Players Analysis
Companies Mentioned
- Ningbo David Medical Device Co.
- Ltd, Koninklijke Philips N.V.
- General Electric Company
- Inapiration Healthcare Group Plc
- Drägerwerk AG & Co. KGaA
- Ibis Medical Equipment and Systems Pvt Ltd.
- Weyer GmbH
- Natus Medical Incorporated.
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 0.1 Billion |
| Forecasted Market Value ( USD | $ 0.14 Billion |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
